Dana-Farber/Boston Children's Cancer and Blood Disorders Center — Boston, Massachusetts

Dana-Farber/Boston Children's Cancer and Blood Disorders Center is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana-Farber/Boston Children's Cancer and Blood Disorders Center has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Acute Lymphoblastic Leukemia, Lymphoblastic Leukemia, Hepatoblastoma.

Sponsors: Jazz Pharmaceuticals, Eureka Therapeutics Inc., SymBio Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber/Boston Children's Cancer and Blood Disorders Center?

Dana-Farber/Boston Children's Cancer and Blood Disorders Center has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber/Boston Children's Cancer and Blood Disorders Center conducted?

Dana-Farber/Boston Children's Cancer and Blood Disorders Center has 3 clinical trials on record, with 2 currently active. Their work covers Acute Lymphoblastic Leukemia, Lymphoblastic Leukemia, Hepatoblastoma.

Is Dana-Farber/Boston Children's Cancer and Blood Disorders Center accredited by Crixeo Health?

Dana-Farber/Boston Children's Cancer and Blood Disorders Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber/Boston Children's Cancer and Blood Disorders Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.